P. Bernard

发表

CGS 8216, a benzodiazepine antagonist, reduces food intake in food-deprived rats

J. Liebman, P. Bernard, G. Pastor, 1986, Pharmacology Biochemistry and Behavior.

Biochemical and behavioral modifications in septal and hypothalamically-lesioned rats.

P. Bernard, M. Poncy, H. I. Chernov, 1972, Neuropharmacology.

CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.

J. Liebman, D. A. Bennett, P. Bernard, 1985, The Journal of pharmacology and experimental therapeutics.

Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.

J. Liebman, D. Wilson, D. A. Bennett, 1989, The Journal of pharmacology and experimental therapeutics.

Antagonism of intrastriatal and intravenous kainic acid by 1-nuciferine: comparison with various anticonvulsants and GABAmimetics.

J. Liebman, P. Bernard, G. Pastor, 1980, Life sciences.

The neuropharmacology of various diazepam antagonists

C. Boast, B. Barbaz, P. Bernard, 1983, Neuropharmacology.

CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.

J. Lehmann, D. A. Bennett, D. Murphy, 1987, The Journal of pharmacology and experimental therapeutics.

Rotometer for recording rotation in chemically or electrically stimulated rats

P. Bernard, R. D. Schwarz, J. W. Stein, 1978, Physiology & Behavior.

A comparison of PCP-like compounds for NMDA antagonism in two in vivo models.

D. A. Bennett, P. Bernard, C. L. Amrick, 1988, Life sciences.

4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors, and anticonvulsant activity.

M. Williams, D. Murphy, P. Bernard, 1989, Journal of medicinal chemistry.

Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones.

R. A. Lovell, W. D. Cash, J. L. Hyun, 1991, Journal of medicinal chemistry.

CGS 7525A, a new, centrally active alpha 2 adrenoceptor antagonist.

R. A. Lovell, H. Kim, J. Liebman, 1983, Life sciences.

Pharmacological characterization of CGS 17867A as a benzodiazepine receptor agonist devoid of limiting behavioral effects

J. Liebman, K. Klebs, M. Schmutz, 1987 .

Behavioral pharmacological profile of CGS 9895: A novel anxiomodulator with selective benzodiazepine agonist and antagonist properties

J. Liebman, D. A. Bennett, P. Bernard, 1985 .

Pharmacological alteration of hyper-reactivity in rats with septal and hypothalamic lesions.

C. Beattie, P. Bernard, H. I. Chernov, 1969, International journal of neuropharmacology.

Benzodiazepine receptor ligands with opposing pharmacologic actions.

A. Czernik, J. Cassidy, P. Bernard, 1983, Advances in biochemical psychopharmacology.

Baclofen as an analgesic

P. Bernard, J. K. Saelens, Douglas E. Wilson, 1980, Brain Research Bulletin.

CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties.

J. Liebman, P. Wood, J. Lehmann, 1990, Progress in clinical and biological research.

Comparative neurological and anticonvulsant effects of baclofen (BF), muscimol (MC), diazepam (DZ) and γ-butyrolactone (GBL)

P. Bernard, R. Sobiski, K. Dawson, 1979, Brain Research Bulletin.

Antagonism of a kainic acid syndrome by baclofen and other putative GABAmimetics

P. Bernard, R. Sobiski, K. Dawson, 1980, Brain Research Bulletin.